nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyclizine—CYP2C9—Formoterol—chronic obstructive pulmonary disease	0.188	0.363	CbGbCtD
Cyclizine—CYP2C9—Arformoterol—chronic obstructive pulmonary disease	0.188	0.363	CbGbCtD
Cyclizine—CYP2C9—Montelukast—chronic obstructive pulmonary disease	0.142	0.275	CbGbCtD
Cyclizine—SULT1E1—Estrogen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.016	0.0958	CbGpPWpGaD
Cyclizine—SULT1E1—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.0141	0.0846	CbGpPWpGaD
Cyclizine—SULT1E1—Estrogen metabolism—GSTM1—chronic obstructive pulmonary disease	0.0122	0.0734	CbGpPWpGaD
Cyclizine—SULT1E1—respiratory system—chronic obstructive pulmonary disease	0.0119	0.327	CbGeAlD
Cyclizine—SULT1E1—Estrogen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.0116	0.0696	CbGpPWpGaD
Cyclizine—SULT1E1—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.0102	0.0615	CbGpPWpGaD
Cyclizine—SULT1E1—bronchus—chronic obstructive pulmonary disease	0.00976	0.269	CbGeAlD
Cyclizine—Hepatitis cholestatic—Montelukast—chronic obstructive pulmonary disease	0.00858	0.0324	CcSEcCtD
Cyclizine—SULT1E1—lung—chronic obstructive pulmonary disease	0.00629	0.173	CbGeAlD
Cyclizine—SULT1E1—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.00623	0.0374	CbGpPWpGaD
Cyclizine—SULT1E1—Phase II conjugation—GSTT1—chronic obstructive pulmonary disease	0.00539	0.0324	CbGpPWpGaD
Cyclizine—SULT1E1—Phase II conjugation—GCLC—chronic obstructive pulmonary disease	0.00533	0.032	CbGpPWpGaD
Cyclizine—SULT1E1—Phase II conjugation—CYP1A2—chronic obstructive pulmonary disease	0.00448	0.0269	CbGpPWpGaD
Cyclizine—Disorientation—Aminophylline—chronic obstructive pulmonary disease	0.00376	0.0142	CcSEcCtD
Cyclizine—SULT1E1—Phase II conjugation—GSTP1—chronic obstructive pulmonary disease	0.00374	0.0224	CbGpPWpGaD
Cyclizine—Hepatobiliary disease—Roflumilast—chronic obstructive pulmonary disease	0.00368	0.0139	CcSEcCtD
Cyclizine—Trimethaphan—CHRNA3—chronic obstructive pulmonary disease	0.0036	0.263	CrCbGaD
Cyclizine—SULT1E1—Phase II conjugation—GSTM1—chronic obstructive pulmonary disease	0.00344	0.0206	CbGpPWpGaD
Cyclizine—Connective tissue disorder—Roflumilast—chronic obstructive pulmonary disease	0.00343	0.0129	CcSEcCtD
Cyclizine—CYP2C9—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A2—chronic obstructive pulmonary disease	0.00329	0.0198	CbGpPWpGaD
Cyclizine—Urinary retention—Aminophylline—chronic obstructive pulmonary disease	0.0032	0.0121	CcSEcCtD
Cyclizine—SULT1E1—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.00316	0.0189	CbGpPWpGaD
Cyclizine—SULT1E1—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.00312	0.0187	CbGpPWpGaD
Cyclizine—Mental disorder—Roflumilast—chronic obstructive pulmonary disease	0.00306	0.0115	CcSEcCtD
Cyclizine—CYP2C9—Arachidonate Epoxygenase / Epoxide Hydrolase—GSTP1—chronic obstructive pulmonary disease	0.00305	0.0183	CbGpPWpGaD
Cyclizine—Urinary retention—Tiotropium—chronic obstructive pulmonary disease	0.00302	0.0114	CcSEcCtD
Cyclizine—CYP2C9—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A2—chronic obstructive pulmonary disease	0.003	0.018	CbGpPWpGaD
Cyclizine—Tension—Roflumilast—chronic obstructive pulmonary disease	0.00298	0.0113	CcSEcCtD
Cyclizine—Nervousness—Roflumilast—chronic obstructive pulmonary disease	0.00295	0.0111	CcSEcCtD
Cyclizine—Muscle spasms—Roflumilast—chronic obstructive pulmonary disease	0.00292	0.011	CcSEcCtD
Cyclizine—Tremor—Roflumilast—chronic obstructive pulmonary disease	0.00285	0.0107	CcSEcCtD
Cyclizine—Disorientation—Montelukast—chronic obstructive pulmonary disease	0.0028	0.0106	CcSEcCtD
Cyclizine—Angioedema—Roflumilast—chronic obstructive pulmonary disease	0.00278	0.0105	CcSEcCtD
Cyclizine—Blister—Prednisolone—chronic obstructive pulmonary disease	0.00265	0.01	CcSEcCtD
Cyclizine—SULT1E1—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.00262	0.0157	CbGpPWpGaD
Cyclizine—SULT1E1—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.00259	0.0155	CbGpPWpGaD
Cyclizine—Nervous system disorder—Roflumilast—chronic obstructive pulmonary disease	0.00243	0.00918	CcSEcCtD
Cyclizine—Skin disorder—Roflumilast—chronic obstructive pulmonary disease	0.00241	0.00909	CcSEcCtD
Cyclizine—CYP2C9—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A1—chronic obstructive pulmonary disease	0.00239	0.0144	CbGpPWpGaD
Cyclizine—Insomnia—Roflumilast—chronic obstructive pulmonary disease	0.00224	0.00846	CcSEcCtD
Cyclizine—SULT1E1—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.00219	0.0131	CbGpPWpGaD
Cyclizine—Bronchospasm—Formoterol—chronic obstructive pulmonary disease	0.00218	0.00821	CcSEcCtD
Cyclizine—Bronchospasm—Arformoterol—chronic obstructive pulmonary disease	0.00218	0.00821	CcSEcCtD
Cyclizine—CYP2C9—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A1—chronic obstructive pulmonary disease	0.00218	0.0131	CbGpPWpGaD
Cyclizine—SULT1E1—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.00216	0.0129	CbGpPWpGaD
Cyclizine—Connective tissue disorder—Tiotropium—chronic obstructive pulmonary disease	0.00216	0.00814	CcSEcCtD
Cyclizine—Constipation—Roflumilast—chronic obstructive pulmonary disease	0.00212	0.008	CcSEcCtD
Cyclizine—HRH1—respiratory system—chronic obstructive pulmonary disease	0.00212	0.0584	CbGeAlD
Cyclizine—Bronchospasm—Salbutamol—chronic obstructive pulmonary disease	0.00206	0.00776	CcSEcCtD
Cyclizine—Eye disorder—Tiotropium—chronic obstructive pulmonary disease	0.00205	0.00774	CcSEcCtD
Cyclizine—SULT1E1—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.00201	0.0121	CbGpPWpGaD
Cyclizine—Tension—Aminophylline—chronic obstructive pulmonary disease	0.00199	0.0075	CcSEcCtD
Cyclizine—SULT1E1—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	0.00198	0.0119	CbGpPWpGaD
Cyclizine—Urticaria—Roflumilast—chronic obstructive pulmonary disease	0.00197	0.00743	CcSEcCtD
Cyclizine—Nervousness—Aminophylline—chronic obstructive pulmonary disease	0.00197	0.00743	CcSEcCtD
Cyclizine—Drowsiness—Montelukast—chronic obstructive pulmonary disease	0.00193	0.00729	CcSEcCtD
Cyclizine—Mental disorder—Tiotropium—chronic obstructive pulmonary disease	0.00192	0.00726	CcSEcCtD
Cyclizine—SULT1E1—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.00191	0.0114	CbGpPWpGaD
Cyclizine—Tremor—Aminophylline—chronic obstructive pulmonary disease	0.0019	0.00716	CcSEcCtD
Cyclizine—SULT1E1—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	0.00188	0.0113	CbGpPWpGaD
Cyclizine—HRH1—connective tissue—chronic obstructive pulmonary disease	0.00187	0.0514	CbGeAlD
Cyclizine—Drowsiness—Salbutamol—chronic obstructive pulmonary disease	0.00186	0.00703	CcSEcCtD
Cyclizine—Agitation—Aminophylline—chronic obstructive pulmonary disease	0.00186	0.00703	CcSEcCtD
Cyclizine—Hepatobiliary disease—Montelukast—chronic obstructive pulmonary disease	0.00183	0.0069	CcSEcCtD
Cyclizine—Hypersensitivity—Roflumilast—chronic obstructive pulmonary disease	0.00183	0.00689	CcSEcCtD
Cyclizine—Vision blurred—Tiotropium—chronic obstructive pulmonary disease	0.0018	0.0068	CcSEcCtD
Cyclizine—Asthenia—Roflumilast—chronic obstructive pulmonary disease	0.00178	0.00671	CcSEcCtD
Cyclizine—Convulsion—Aminophylline—chronic obstructive pulmonary disease	0.00176	0.00662	CcSEcCtD
Cyclizine—Angioedema—Tiotropium—chronic obstructive pulmonary disease	0.00175	0.00659	CcSEcCtD
Cyclizine—Connective tissue disorder—Formoterol—chronic obstructive pulmonary disease	0.00174	0.00657	CcSEcCtD
Cyclizine—Connective tissue disorder—Arformoterol—chronic obstructive pulmonary disease	0.00174	0.00657	CcSEcCtD
Cyclizine—Hepatitis—Montelukast—chronic obstructive pulmonary disease	0.00173	0.00655	CcSEcCtD
Cyclizine—HRH1—smooth muscle tissue—chronic obstructive pulmonary disease	0.00171	0.047	CbGeAlD
Cyclizine—Connective tissue disorder—Montelukast—chronic obstructive pulmonary disease	0.0017	0.00643	CcSEcCtD
Cyclizine—Anaphylactic shock—Aminophylline—chronic obstructive pulmonary disease	0.00165	0.00624	CcSEcCtD
Cyclizine—Hypertension—Tiotropium—chronic obstructive pulmonary disease	0.00165	0.00623	CcSEcCtD
Cyclizine—Connective tissue disorder—Salbutamol—chronic obstructive pulmonary disease	0.00164	0.0062	CcSEcCtD
Cyclizine—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.00164	0.00619	CcSEcCtD
Cyclizine—Nervous system disorder—Aminophylline—chronic obstructive pulmonary disease	0.00162	0.00612	CcSEcCtD
Cyclizine—Tachycardia—Aminophylline—chronic obstructive pulmonary disease	0.00161	0.00609	CcSEcCtD
Cyclizine—Thrombophlebitis—Prednisolone—chronic obstructive pulmonary disease	0.0016	0.00605	CcSEcCtD
Cyclizine—CYP2C9—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.00158	0.00949	CbGpPWpGaD
Cyclizine—HRH1—trachea—chronic obstructive pulmonary disease	0.00157	0.0432	CbGeAlD
Cyclizine—HRH1—Monoamine GPCRs—ADRB2—chronic obstructive pulmonary disease	0.00156	0.00937	CbGpPWpGaD
Cyclizine—Headache—Roflumilast—chronic obstructive pulmonary disease	0.00155	0.00586	CcSEcCtD
Cyclizine—Mental disorder—Arformoterol—chronic obstructive pulmonary disease	0.00155	0.00586	CcSEcCtD
Cyclizine—Mental disorder—Formoterol—chronic obstructive pulmonary disease	0.00155	0.00586	CcSEcCtD
Cyclizine—Hypotension—Aminophylline—chronic obstructive pulmonary disease	0.00155	0.00583	CcSEcCtD
Cyclizine—SULT1E1—Metabolism—APIP—chronic obstructive pulmonary disease	0.00153	0.0092	CbGpPWpGaD
Cyclizine—Nervous system disorder—Tiotropium—chronic obstructive pulmonary disease	0.00153	0.00577	CcSEcCtD
Cyclizine—Tachycardia—Tiotropium—chronic obstructive pulmonary disease	0.00152	0.00574	CcSEcCtD
Cyclizine—CYP2C9—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00152	0.00913	CbGpPWpGaD
Cyclizine—Mental disorder—Montelukast—chronic obstructive pulmonary disease	0.00152	0.00574	CcSEcCtD
Cyclizine—Skin disorder—Tiotropium—chronic obstructive pulmonary disease	0.00151	0.00572	CcSEcCtD
Cyclizine—Tension—Arformoterol—chronic obstructive pulmonary disease	0.00151	0.00571	CcSEcCtD
Cyclizine—Tension—Formoterol—chronic obstructive pulmonary disease	0.00151	0.00571	CcSEcCtD
Cyclizine—Chills—Salbutamol—chronic obstructive pulmonary disease	0.0015	0.00566	CcSEcCtD
Cyclizine—Nervousness—Formoterol—chronic obstructive pulmonary disease	0.0015	0.00565	CcSEcCtD
Cyclizine—Nervousness—Arformoterol—chronic obstructive pulmonary disease	0.0015	0.00565	CcSEcCtD
Cyclizine—Insomnia—Aminophylline—chronic obstructive pulmonary disease	0.0015	0.00564	CcSEcCtD
Cyclizine—Muscle spasms—Arformoterol—chronic obstructive pulmonary disease	0.00148	0.00559	CcSEcCtD
Cyclizine—Muscle spasms—Formoterol—chronic obstructive pulmonary disease	0.00148	0.00559	CcSEcCtD
Cyclizine—Mental disorder—Salbutamol—chronic obstructive pulmonary disease	0.00147	0.00553	CcSEcCtD
Cyclizine—Muscle spasms—Montelukast—chronic obstructive pulmonary disease	0.00145	0.00548	CcSEcCtD
Cyclizine—Dermatitis bullous—Prednisolone—chronic obstructive pulmonary disease	0.00145	0.00548	CcSEcCtD
Cyclizine—Tremor—Arformoterol—chronic obstructive pulmonary disease	0.00144	0.00545	CcSEcCtD
Cyclizine—Tremor—Formoterol—chronic obstructive pulmonary disease	0.00144	0.00545	CcSEcCtD
Cyclizine—Tension—Salbutamol—chronic obstructive pulmonary disease	0.00143	0.00539	CcSEcCtD
Cyclizine—Agitation—Arformoterol—chronic obstructive pulmonary disease	0.00142	0.00535	CcSEcCtD
Cyclizine—Agitation—Formoterol—chronic obstructive pulmonary disease	0.00142	0.00535	CcSEcCtD
Cyclizine—Tremor—Montelukast—chronic obstructive pulmonary disease	0.00142	0.00534	CcSEcCtD
Cyclizine—Nervousness—Salbutamol—chronic obstructive pulmonary disease	0.00141	0.00534	CcSEcCtD
Cyclizine—Insomnia—Tiotropium—chronic obstructive pulmonary disease	0.00141	0.00532	CcSEcCtD
Cyclizine—Angioedema—Formoterol—chronic obstructive pulmonary disease	0.00141	0.00532	CcSEcCtD
Cyclizine—Angioedema—Arformoterol—chronic obstructive pulmonary disease	0.00141	0.00532	CcSEcCtD
Cyclizine—Paraesthesia—Tiotropium—chronic obstructive pulmonary disease	0.0014	0.00528	CcSEcCtD
Cyclizine—Muscle spasms—Salbutamol—chronic obstructive pulmonary disease	0.0014	0.00528	CcSEcCtD
Cyclizine—Agitation—Montelukast—chronic obstructive pulmonary disease	0.00139	0.00524	CcSEcCtD
Cyclizine—Angioedema—Montelukast—chronic obstructive pulmonary disease	0.00138	0.00521	CcSEcCtD
Cyclizine—Tremor—Salbutamol—chronic obstructive pulmonary disease	0.00136	0.00515	CcSEcCtD
Cyclizine—Agitation—Salbutamol—chronic obstructive pulmonary disease	0.00134	0.00505	CcSEcCtD
Cyclizine—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.00133	0.00503	CcSEcCtD
Cyclizine—Hypertension—Arformoterol—chronic obstructive pulmonary disease	0.00133	0.00502	CcSEcCtD
Cyclizine—Hypertension—Formoterol—chronic obstructive pulmonary disease	0.00133	0.00502	CcSEcCtD
Cyclizine—Angioedema—Salbutamol—chronic obstructive pulmonary disease	0.00133	0.00502	CcSEcCtD
Cyclizine—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.00131	0.00496	CcSEcCtD
Cyclizine—HRH1—Amine ligand-binding receptors—ADRB2—chronic obstructive pulmonary disease	0.00131	0.00787	CbGpPWpGaD
Cyclizine—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.00131	0.00494	CcSEcCtD
Cyclizine—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.00126	0.00475	CcSEcCtD
Cyclizine—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.00126	0.00475	CcSEcCtD
Cyclizine—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.00126	0.00474	CcSEcCtD
Cyclizine—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.00124	0.00468	CcSEcCtD
Cyclizine—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.00123	0.00466	CcSEcCtD
Cyclizine—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.00123	0.00466	CcSEcCtD
Cyclizine—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.00123	0.00465	CcSEcCtD
Cyclizine—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.00123	0.00464	CcSEcCtD
Cyclizine—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.00123	0.00464	CcSEcCtD
Cyclizine—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.00122	0.00461	CcSEcCtD
Cyclizine—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.00122	0.00461	CcSEcCtD
Cyclizine—HRH1—Monoamine GPCRs—HTR2A—chronic obstructive pulmonary disease	0.00122	0.00732	CbGpPWpGaD
Cyclizine—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.00122	0.0046	CcSEcCtD
Cyclizine—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.00121	0.00456	CcSEcCtD
Cyclizine—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.0012	0.00452	CcSEcCtD
Cyclizine—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.00119	0.00448	CcSEcCtD
Cyclizine—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.00118	0.00444	CcSEcCtD
Cyclizine—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.00118	0.00444	CcSEcCtD
Cyclizine—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.00117	0.00441	CcSEcCtD
Cyclizine—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.00117	0.0044	CcSEcCtD
Cyclizine—Thrombophlebitis—Prednisone—chronic obstructive pulmonary disease	0.00116	0.00439	CcSEcCtD
Cyclizine—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.00116	0.00438	CcSEcCtD
Cyclizine—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.00115	0.00436	CcSEcCtD
Cyclizine—CYP2C9—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.00115	0.00689	CbGpPWpGaD
Cyclizine—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.00115	0.00434	CcSEcCtD
Cyclizine—Reboxetine—SLC6A4—chronic obstructive pulmonary disease	0.00115	0.084	CrCbGaD
Cyclizine—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.00114	0.0043	CcSEcCtD
Cyclizine—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.00114	0.0043	CcSEcCtD
Cyclizine—HRH1—lung—chronic obstructive pulmonary disease	0.00113	0.031	CbGeAlD
Cyclizine—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.00112	0.00422	CcSEcCtD
Cyclizine—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.00112	0.00422	CcSEcCtD
Cyclizine—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.00111	0.00421	CcSEcCtD
Cyclizine—Meclizine—CYP1A2—chronic obstructive pulmonary disease	0.00111	0.0814	CrCbGaD
Cyclizine—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.00111	0.00419	CcSEcCtD
Cyclizine—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.00111	0.00418	CcSEcCtD
Cyclizine—CYP2C9—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.0011	0.00663	CbGpPWpGaD
Cyclizine—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.0011	0.00416	CcSEcCtD
Cyclizine—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.0011	0.00414	CcSEcCtD
Cyclizine—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.00109	0.00413	CcSEcCtD
Cyclizine—Pain—Arformoterol—chronic obstructive pulmonary disease	0.00108	0.00406	CcSEcCtD
Cyclizine—Constipation—Formoterol—chronic obstructive pulmonary disease	0.00108	0.00406	CcSEcCtD
Cyclizine—Pain—Formoterol—chronic obstructive pulmonary disease	0.00108	0.00406	CcSEcCtD
Cyclizine—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.00108	0.00406	CcSEcCtD
Cyclizine—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.00107	0.00406	CcSEcCtD
Cyclizine—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.00107	0.00403	CcSEcCtD
Cyclizine—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.00106	0.00399	CcSEcCtD
Cyclizine—Pain—Montelukast—chronic obstructive pulmonary disease	0.00105	0.00398	CcSEcCtD
Cyclizine—Headache—Aminophylline—chronic obstructive pulmonary disease	0.00104	0.00391	CcSEcCtD
Cyclizine—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.00103	0.00621	CbGpPWpGaD
Cyclizine—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.00103	0.00389	CcSEcCtD
Cyclizine—HRH1—Amine ligand-binding receptors—HTR2A—chronic obstructive pulmonary disease	0.00103	0.00615	CbGpPWpGaD
Cyclizine—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.00102	0.00383	CcSEcCtD
Cyclizine—Pain—Salbutamol—chronic obstructive pulmonary disease	0.00102	0.00383	CcSEcCtD
Cyclizine—SULT1E1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.00102	0.00609	CbGpPWpGaD
Cyclizine—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.001	0.00377	CcSEcCtD
Cyclizine—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.001	0.00377	CcSEcCtD
Cyclizine—SULT1E1—Metabolism—GC—chronic obstructive pulmonary disease	0.000988	0.00593	CbGpPWpGaD
Cyclizine—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000979	0.0037	CcSEcCtD
Cyclizine—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000977	0.00369	CcSEcCtD
Cyclizine—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000944	0.00356	CcSEcCtD
Cyclizine—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000927	0.0035	CcSEcCtD
Cyclizine—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000927	0.0035	CcSEcCtD
Cyclizine—SULT1E1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000918	0.00551	CbGpPWpGaD
Cyclizine—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000908	0.00343	CcSEcCtD
Cyclizine—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000903	0.00341	CcSEcCtD
Cyclizine—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000903	0.00341	CcSEcCtD
Cyclizine—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.00089	0.00336	CcSEcCtD
Cyclizine—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.00089	0.00336	CcSEcCtD
Cyclizine—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000884	0.00334	CcSEcCtD
Cyclizine—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000875	0.0033	CcSEcCtD
Cyclizine—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000872	0.00329	CcSEcCtD
Cyclizine—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000853	0.00322	CcSEcCtD
Cyclizine—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000841	0.00317	CcSEcCtD
Cyclizine—Erythema—Prednisolone—chronic obstructive pulmonary disease	0.000835	0.00315	CcSEcCtD
Cyclizine—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000832	0.00314	CcSEcCtD
Cyclizine—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000832	0.00314	CcSEcCtD
Cyclizine—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000815	0.00308	CcSEcCtD
Cyclizine—Headache—Formoterol—chronic obstructive pulmonary disease	0.000788	0.00298	CcSEcCtD
Cyclizine—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000788	0.00298	CcSEcCtD
Cyclizine—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.000787	0.00297	CcSEcCtD
Cyclizine—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000786	0.00297	CcSEcCtD
Cyclizine—Headache—Montelukast—chronic obstructive pulmonary disease	0.000772	0.00291	CcSEcCtD
Cyclizine—Angioedema—Prednisolone—chronic obstructive pulmonary disease	0.000763	0.00288	CcSEcCtD
Cyclizine—CYP2C9—Arachidonic acid metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00076	0.00456	CbGpPWpGaD
Cyclizine—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000744	0.00281	CcSEcCtD
Cyclizine—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.000724	0.00273	CcSEcCtD
Cyclizine—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.000721	0.00272	CcSEcCtD
Cyclizine—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	0.000685	0.00259	CcSEcCtD
Cyclizine—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.000682	0.00257	CcSEcCtD
Cyclizine—CYP2C9—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000672	0.00403	CbGpPWpGaD
Cyclizine—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.000665	0.00251	CcSEcCtD
Cyclizine—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000657	0.00394	CbGpPWpGaD
Cyclizine—Eye disorder—Prednisone—chronic obstructive pulmonary disease	0.000651	0.00246	CcSEcCtD
Cyclizine—CYP2C9—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000648	0.00389	CbGpPWpGaD
Cyclizine—Flunarizine—CYP1A1—chronic obstructive pulmonary disease	0.000621	0.0455	CrCbGaD
Cyclizine—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000616	0.00233	CcSEcCtD
Cyclizine—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.000612	0.00231	CcSEcCtD
Cyclizine—Mental disorder—Prednisone—chronic obstructive pulmonary disease	0.000611	0.0023	CcSEcCtD
Cyclizine—Erythema—Prednisone—chronic obstructive pulmonary disease	0.000607	0.00229	CcSEcCtD
Cyclizine—Flunarizine—CYP1A2—chronic obstructive pulmonary disease	0.000599	0.0438	CrCbGaD
Cyclizine—Pain—Prednisolone—chronic obstructive pulmonary disease	0.000583	0.0022	CcSEcCtD
Cyclizine—Vision blurred—Prednisone—chronic obstructive pulmonary disease	0.000572	0.00216	CcSEcCtD
Cyclizine—Agitation—Prednisone—chronic obstructive pulmonary disease	0.000558	0.0021	CcSEcCtD
Cyclizine—Angioedema—Prednisone—chronic obstructive pulmonary disease	0.000554	0.00209	CcSEcCtD
Cyclizine—CYP2C9—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000552	0.00331	CbGpPWpGaD
Cyclizine—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000541	0.00204	CcSEcCtD
Cyclizine—SULT1E1—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.00054	0.00324	CbGpPWpGaD
Cyclizine—SULT1E1—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000533	0.0032	CbGpPWpGaD
Cyclizine—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000532	0.00319	CbGpPWpGaD
Cyclizine—Convulsion—Prednisone—chronic obstructive pulmonary disease	0.000526	0.00198	CcSEcCtD
Cyclizine—Hypertension—Prednisone—chronic obstructive pulmonary disease	0.000524	0.00198	CcSEcCtD
Cyclizine—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000502	0.00189	CcSEcCtD
Cyclizine—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	0.000495	0.00187	CcSEcCtD
Cyclizine—Cinnarizine—CYP1A1—chronic obstructive pulmonary disease	0.000491	0.0359	CrCbGaD
Cyclizine—Phenoxybenzamine—ADRB2—chronic obstructive pulmonary disease	0.000491	0.0359	CrCbGaD
Cyclizine—Modafinil—CYP1A2—chronic obstructive pulmonary disease	0.00049	0.0358	CrCbGaD
Cyclizine—SULT1E1—Metabolism—CTGF—chronic obstructive pulmonary disease	0.000487	0.00292	CbGpPWpGaD
Cyclizine—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.000486	0.00183	CcSEcCtD
Cyclizine—Tachycardia—Prednisone—chronic obstructive pulmonary disease	0.000483	0.00182	CcSEcCtD
Cyclizine—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.000481	0.00182	CcSEcCtD
Cyclizine—HRH1—GPCRs, Class A Rhodopsin-like—CXCR2—chronic obstructive pulmonary disease	0.00048	0.00288	CbGpPWpGaD
Cyclizine—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000477	0.00286	CbGpPWpGaD
Cyclizine—Cinnarizine—CYP1A2—chronic obstructive pulmonary disease	0.000474	0.0347	CrCbGaD
Cyclizine—CYP2C9—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000471	0.00283	CbGpPWpGaD
Cyclizine—Atomoxetine—SLC6A4—chronic obstructive pulmonary disease	0.000462	0.0338	CrCbGaD
Cyclizine—Cyproheptadine—HTR2A—chronic obstructive pulmonary disease	0.000458	0.0335	CrCbGaD
Cyclizine—Mianserin—SLC6A4—chronic obstructive pulmonary disease	0.000452	0.0331	CrCbGaD
Cyclizine—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000451	0.0017	CcSEcCtD
Cyclizine—SULT1E1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000449	0.00269	CbGpPWpGaD
Cyclizine—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.000448	0.00169	CcSEcCtD
Cyclizine—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.000445	0.00168	CcSEcCtD
Cyclizine—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000427	0.00161	CcSEcCtD
Cyclizine—Constipation—Prednisone—chronic obstructive pulmonary disease	0.000424	0.0016	CcSEcCtD
Cyclizine—Mianserin—CYP1A2—chronic obstructive pulmonary disease	0.000412	0.0301	CrCbGaD
Cyclizine—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCR2—chronic obstructive pulmonary disease	0.000411	0.00247	CbGpPWpGaD
Cyclizine—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.000393	0.00148	CcSEcCtD
Cyclizine—Phenprocoumon—ALB—chronic obstructive pulmonary disease	0.000389	0.0285	CrCbGaD
Cyclizine—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000387	0.00232	CbGpPWpGaD
Cyclizine—SULT1E1—Metabolism—GSTP1—chronic obstructive pulmonary disease	0.000374	0.00224	CbGpPWpGaD
Cyclizine—SULT1E1—Metabolism—HMOX1—chronic obstructive pulmonary disease	0.000369	0.00221	CbGpPWpGaD
Cyclizine—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000365	0.00138	CcSEcCtD
Cyclizine—Loxapine—SLC6A4—chronic obstructive pulmonary disease	0.000359	0.0263	CrCbGaD
Cyclizine—Atomoxetine—HTR2A—chronic obstructive pulmonary disease	0.000355	0.026	CrCbGaD
Cyclizine—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000355	0.00134	CcSEcCtD
Cyclizine—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.00035	0.00132	CcSEcCtD
Cyclizine—HRH1—G alpha (q) signalling events—EDN1—chronic obstructive pulmonary disease	0.000348	0.00209	CbGpPWpGaD
Cyclizine—Mianserin—HTR2A—chronic obstructive pulmonary disease	0.000347	0.0254	CrCbGaD
Cyclizine—SULT1E1—Metabolism—GSTM1—chronic obstructive pulmonary disease	0.000344	0.00206	CbGpPWpGaD
Cyclizine—CYP2C9—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.00034	0.00204	CbGpPWpGaD
Cyclizine—Diphenhydramine—CYP1A2—chronic obstructive pulmonary disease	0.00034	0.0249	CrCbGaD
Cyclizine—CYP2C9—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000336	0.00202	CbGpPWpGaD
Cyclizine—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000327	0.00124	CcSEcCtD
Cyclizine—SULT1E1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000326	0.00196	CbGpPWpGaD
Cyclizine—HRH1—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	0.000313	0.00188	CbGpPWpGaD
Cyclizine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—chronic obstructive pulmonary disease	0.000311	0.00187	CbGpPWpGaD
Cyclizine—Headache—Prednisone—chronic obstructive pulmonary disease	0.00031	0.00117	CcSEcCtD
Cyclizine—HRH1—G alpha (q) signalling events—HTR2A—chronic obstructive pulmonary disease	0.000305	0.00183	CbGpPWpGaD
Cyclizine—HRH1—GPCRs, Class A Rhodopsin-like—ADRB2—chronic obstructive pulmonary disease	0.000301	0.00181	CbGpPWpGaD
Cyclizine—Clozapine—CYP1A1—chronic obstructive pulmonary disease	0.000285	0.0208	CrCbGaD
Cyclizine—CYP2C9—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000283	0.0017	CbGpPWpGaD
Cyclizine—CYP2C9—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.000279	0.00167	CbGpPWpGaD
Cyclizine—Loxapine—HTR2A—chronic obstructive pulmonary disease	0.000276	0.0202	CrCbGaD
Cyclizine—Clozapine—CYP1A2—chronic obstructive pulmonary disease	0.000275	0.0201	CrCbGaD
Cyclizine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—chronic obstructive pulmonary disease	0.000272	0.00163	CbGpPWpGaD
Cyclizine—HRH1—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	0.000258	0.00155	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	0.000257	0.00154	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	0.000239	0.00144	CbGpPWpGaD
Cyclizine—CYP2C9—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000236	0.00142	CbGpPWpGaD
Cyclizine—HRH1—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	0.000235	0.00141	CbGpPWpGaD
Cyclizine—CYP2C9—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.000233	0.0014	CbGpPWpGaD
Cyclizine—Clozapine—HTR2A—chronic obstructive pulmonary disease	0.000232	0.017	CrCbGaD
Cyclizine—HRH1—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	0.000231	0.00138	CbGpPWpGaD
Cyclizine—SULT1E1—Metabolism—ALB—chronic obstructive pulmonary disease	0.000222	0.00133	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	0.00022	0.00132	CbGpPWpGaD
Cyclizine—CYP2C9—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.000217	0.0013	CbGpPWpGaD
Cyclizine—CYP2C9—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	0.000214	0.00128	CbGpPWpGaD
Cyclizine—SULT1E1—Metabolism—NOS3—chronic obstructive pulmonary disease	0.000212	0.00127	CbGpPWpGaD
Cyclizine—CYP2C9—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.000205	0.00123	CbGpPWpGaD
Cyclizine—CYP2C9—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	0.000203	0.00122	CbGpPWpGaD
Cyclizine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	0.000202	0.00121	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	0.000199	0.0012	CbGpPWpGaD
Cyclizine—HRH1—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	0.000196	0.00118	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	0.000177	0.00106	CbGpPWpGaD
Cyclizine—HRH1—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	0.000176	0.00105	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—APIP—chronic obstructive pulmonary disease	0.000165	0.000992	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	0.000161	0.000965	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	0.000155	0.000933	CbGpPWpGaD
Cyclizine—HRH1—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	0.000154	0.000922	CbGpPWpGaD
Cyclizine—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	0.000125	0.000748	CbGpPWpGaD
Cyclizine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—chronic obstructive pulmonary disease	0.000123	0.000738	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	0.000118	0.000707	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	0.000118	0.000707	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	0.000111	0.000666	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000109	0.000657	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	0.000109	0.000652	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—GC—chronic obstructive pulmonary disease	0.000107	0.000639	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	0.000101	0.000605	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	9.92e-05	0.000595	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	9.9e-05	0.000594	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	9.5e-05	0.00057	CbGpPWpGaD
Cyclizine—HRH1—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	9.49e-05	0.000569	CbGpPWpGaD
Cyclizine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic obstructive pulmonary disease	9.45e-05	0.000567	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	9.01e-05	0.000541	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	8.68e-05	0.000521	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	7.89e-05	0.000473	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	7.88e-05	0.000473	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	6.94e-05	0.000417	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—KL—chronic obstructive pulmonary disease	6.45e-05	0.000387	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	5.96e-05	0.000357	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—GSTT1—chronic obstructive pulmonary disease	5.82e-05	0.000349	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—GCLC—chronic obstructive pulmonary disease	5.75e-05	0.000345	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	5.36e-05	0.000322	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	5.36e-05	0.000322	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	5.32e-05	0.000319	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—CTGF—chronic obstructive pulmonary disease	5.25e-05	0.000315	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	4.87e-05	0.000292	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	4.84e-05	0.00029	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—CYP1A2—chronic obstructive pulmonary disease	4.84e-05	0.00029	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	4.66e-05	0.000279	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	4.33e-05	0.00026	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.03e-05	0.000242	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.98e-05	0.000239	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.71e-05	0.000222	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	3.56e-05	0.000214	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.51e-05	0.000211	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	3.4e-05	0.000204	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	3.24e-05	0.000195	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	2.88e-05	0.000173	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	2.74e-05	0.000164	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	2.6e-05	0.000156	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—ALB—chronic obstructive pulmonary disease	2.39e-05	0.000143	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2.34e-05	0.00014	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—NOS3—chronic obstructive pulmonary disease	2.28e-05	0.000137	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.14e-05	0.000129	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.1e-05	0.000126	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.77e-05	0.000106	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.62e-05	9.7e-05	CbGpPWpGaD
